Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Nervous System Drugs > PRL-8-53 for Sale > High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5
High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5 buy - large image1
High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5 buy - image1
High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5 buy - image2
High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5 buy - image3
High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5 buy - image4

High-Quality Medicine Grade Nootropic Prl-8-53 CAS 51352-87-5

TDS 14 Inquiries

Unit Price:

$1/KG FOB

Get Latest Price
CAS No.:

51352-87-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

1

Brand:

Million

Packaging:

25kg/Cardboard Drum

Sample Available:

Yes

Price valid (until):

2026-11-21

Company Type:
Manufactory
Location:
China
Payment Terms:
L/C,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Shop 4-AMino-5-Methylpyridin-2-ol Finerenone cas95306-64-2  best service high quality-Detailed Image 1

    -Product Descrition-

    PRL-8-53 is an experimental compound belonging to the benzamide class with potential cognitive-enhancing properties. It may modulate memory formation and consolidation by interacting with specific central nervous system receptors. PRL-8-53 is primarily used in neuroscience research as an exploratory tool to study the mechanisms of learning and memory, but its manipulation requires controlled laboratory conditions.

            Shop High Quality CP Standard Citicoline Sodium-choline CAS 33818-15-4-Detailed Image 2 Shop High Quality CP Standard Citicoline Sodium-choline CAS 33818-15-4-Detailed Image 3


    Why Choose Us ?

    1 、  Manufacturer supply, best price and service.

    2、  Safe fast delivery.

    3、  F   ree sample.

    4、 Large stock.

    5、  Easy payment: bank transfer,  moneygram, paypal....

    6、  Good reputation, great feedback.

    7、  Customers worldwide:   Metrochem Api Pvt Ltd;Bdr Lifesciences Pvt.Ltd;Srini Chem;Eva Pharma;Pharmaffiliates Analytics&Synthetics(p)Ltd;....From India,Egypt,Canada ....


    -Packing&Shipping-

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 3


    Ship methods

    Special line

    Express

    By air

    By sea

    DHL/TNT/FeDex/UPS

    Delivery

    7-15 days

    3-10 days

    3-5 days

    10-30 days

    Service

    Door to door

    Door to door

    To airport

    To seaport

    Customs clearance

    No

    Possible

    Yes

    Yes


    -Company Profile-

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 4

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 5


    About us:

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
       Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixab a n, Lurasidon e , Bexagliflozin, Vortioxetine, L OXO -292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...


    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
       The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
       Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.


    -Certification- Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 6

    ECHEMI Editorial Reference
    PRL-8-53 is an experimental compound which many believe to be one of the most effective memory boosters available.It is a nootropic research chemical derived from benzoic acid and phenylmethylamine with memory-enhancing effects, used in neuroscience research related to memory enhancement and protection against memory impairment.
    The drug name of PRL-8-53 is methyl 3-2-benzyl methyl amino ethyl benzoate. It is a promising supplement that was developed in 1972 by Dr. Nikolaus Hansl at Creighton University.Rumors and a few documents revealed that Dr. Hansl, PRL-8-147, also created a stronger version of PRL-8-53.In 1978, Dr. Hansl conducted a human study where volunteers doubled their memory with a single dose.This discovery made PRL-8-53 the most talked-about nootropics in the market.Neurohackers even tagged it as a powerful supplement that boosts memory formation, retention, and recall improving the overall cognitive function.

    Certificates

    Basic Info
    Product Name:

    PRL-8-53

    Other Name:

    PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;PRL-8-53 HCL;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride;Methyl 3-(2-(benzyl(methyl)

    CAS No.:

    51352-87-5

    Molecular Formula:

    C18H22ClNO2

    InChIKeys:

    HLBBSWSJLPLPRU-UHFFFAOYSA-N

    Molecular Weight:

    319.82578

    EC Number:

    206-141-6

    Categories:

    Nervous System Drugs

    Characteristics
    Toxicity:

    PRL-8-53 is relatively non-toxic, with an oral LD50 in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in canines. High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic effects.

    Critical Temperature & Pressure:

    under inert gas (nitrogen or Argon) at 2-8°C

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

    Location:

    Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China

    Payment Terms:

    L/C,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2012

    Company Certificates
    • Jinan Million Pharmaceutical Co., Ltdbusiness license business license

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
    Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixaban, Lurasidone, Bexagliflozin, Votioxitine, Loxo-292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; INCETPAT PHARM; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...



    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
    The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
    Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

  • Inquiry History
    14 Inquiries
    Country Product Purchase Quantity Date Posted
    Philippines

    PRL-8-53

    1 KG Aug 26, 2026
    Russia

    PRL-8-53

    10.00 G Aug 14, 2024
    United States

    PRL-8-53

    1 G Sep 28, 2026
    United States

    PRL-8-53

    1 G Feb 2, 2025
    United States

    PRL-8-53

    10 PCS Oct 1, 2026
    Russia

    Sofosbuvir

    68.00 G Aug 14, 2024
    Russia

    7,8-Dihydroxyflavone

    75.00 G Aug 14, 2024
    Russia

    Citicoline sodium

    750.00 G Aug 14, 2024
    Russia

    Enclomiphene

    100.00 G Aug 14, 2024
    Russia

    Velpatasvir

    17.00 G Aug 14, 2024
    Russia

    NNMTi

    15.00 G Aug 14, 2024
    Russia

    Unifiram

    30.00 G Aug 14, 2024
    Russia

    Coluracetam

    100.00 G Aug 14, 2024
    Russia

    DIHEXA

    50.00 G Aug 14, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.